Evotec SE (EVO) Operating Income Growth (1y) (2010 - 2025)
Evotec SE (EVO) Operating Income Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 32.62 Bn | 30.68 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | -14.89% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 21.25% |
| 10 | Evotec SE | 345.39 Mn | 344.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 635.29% |
| Sep 30, 2025 | -78.81% |
| Dec 31, 2024 | 115.47% |
| Sep 30, 2024 | -319.31% |
| Dec 31, 2023 | -125.25% |
| Sep 30, 2023 | -2.74% |
| Jun 30, 2023 | -882.27% |
| Dec 31, 2022 | -157.63% |
| Sep 30, 2022 | -34.79% |
| Jun 30, 2022 | -149.28% |
| Mar 31, 2022 | 14.55% |
| Dec 31, 2021 | -84.98% |
| Sep 30, 2021 | -3.44% |
| Dec 31, 2020 | -99.71% |
| Jun 30, 2010 | 119.17% |
| Mar 31, 2010 | -100.00% |